位置:首页 > 蛋白库 > SPRE_DICDI
SPRE_DICDI
ID   SPRE_DICDI              Reviewed;         267 AA.
AC   Q54GP3; Q9NGC5;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   03-AUG-2022, entry version 108.
DE   RecName: Full=Sepiapterin reductase {ECO:0000303|PubMed:10987137, ECO:0000303|PubMed:15896778};
DE            Short=SPR;
DE            Short=SR {ECO:0000303|PubMed:10987137, ECO:0000303|PubMed:15896778};
DE            EC=1.1.1.153 {ECO:0000269|PubMed:10987137, ECO:0000269|PubMed:15896778, ECO:0000269|PubMed:16527408};
GN   Name=sprA; ORFNames=DDB_G0290009;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Evosea; Eumycetozoa; Dictyostelia; Dictyosteliales;
OC   Dictyosteliaceae; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A., Sucgang R.,
RA   Berriman M., Song J., Olsen R., Szafranski K., Xu Q., Tunggal B.,
RA   Kummerfeld S., Madera M., Konfortov B.A., Rivero F., Bankier A.T.,
RA   Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P., Pilcher K., Chen G.,
RA   Saunders D., Sodergren E.J., Davis P., Kerhornou A., Nie X., Hall N.,
RA   Anjard C., Hemphill L., Bason N., Farbrother P., Desany B., Just E.,
RA   Morio T., Rost R., Churcher C.M., Cooper J., Haydock S., van Driessche N.,
RA   Cronin A., Goodhead I., Muzny D.M., Mourier T., Pain A., Lu M., Harper D.,
RA   Lindsay R., Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C., Quail M.A.,
RA   Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D., Sanders M.,
RA   Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S., Tivey A.,
RA   Sugano S., White B., Walker D., Woodward J.R., Winckler T., Tanaka Y.,
RA   Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A., Cox E.C.,
RA   Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M., Kay R.R.,
RA   Williams J.G., Dear P.H., Noegel A.A., Barrell B.G., Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-267, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY REGULATION.
RC   STRAIN=AX2;
RX   PubMed=10987137;
RA   Kim Y.-A., Chung H.J., Kim Y.J., Choi Y.K., Hwang Y.K., Lee S.W.,
RA   Park Y.S.;
RT   "Characterization of recombinant Dictyostelium discoideum sepiapterin
RT   reductase expressed in E. coli.";
RL   Mol. Cells 10:405-410(2000).
RN   [3]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND CATALYTIC ACTIVITY.
RC   STRAIN=AX2;
RX   PubMed=15896778; DOI=10.1016/j.febslet.2005.04.064;
RA   Choi Y.K., Park J.S., Kong J.S., Morio T., Park Y.S.;
RT   "D-threo-tetrahydrobiopterin is synthesized via 1'-oxo-2'-D-hydroxypropyl-
RT   tetrahydropterin in Dictyostelium discoideum Ax2.";
RL   FEBS Lett. 579:3085-3089(2005).
RN   [4]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=AX2;
RX   PubMed=16527408; DOI=10.1016/j.bbagen.2005.11.017;
RA   Choi Y.K., Kong J.S., Park Y.S.;
RT   "Functional role of sepiapterin reductase in the biosynthesis of
RT   tetrahydropteridines in Dictyostelium discoideum Ax2.";
RL   Biochim. Biophys. Acta 1760:877-882(2006).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=AX2;
RX   PubMed=17976377; DOI=10.1016/j.febslet.2007.10.044;
RA   Kim H.L., Choi Y.K., Kim do H., Park S.O., Han J., Park Y.S.;
RT   "Tetrahydropteridine deficiency impairs mitochondrial function in
RT   Dictyostelium discoideum Ax2.";
RL   FEBS Lett. 581:5430-5434(2007).
CC   -!- FUNCTION: Catalyzes the production of D-threo-tetrahydrobiopterin
CC       (tetrahydrodictyopterin or DH4), also known as dictyopterin, and in a
CC       much smaller amount that of it's stereoisomer L-erythro-
CC       tetrahydrobiopterin ((6R)-L-erythro-5,6,7,8-tetrahydrobiopterin or BH4)
CC       (PubMed:16527408). Prefers 1-oxo-2-D-hydroxypropyl-tetrahydropterin to
CC       6-pyruvoyltetrahydropterin (6-pyruvoyl-5,6,7,8-tetrahydropterin) as a
CC       substrate, thereby maintaining dominant production of DH4 over BH4 in
CC       sufficient supply of an aldose reductase-like enzyme (PubMed:16527408).
CC       DH4 represents more than 95% of the total tetrahydrobiopterin
CC       production. It has a direct antioxidant function to protect
CC       mitochondria against oxidative stress (PubMed:17976377). Essential for
CC       the last step of BH4 synthesis (PubMed:10987137, PubMed:15896778). Also
CC       catalyzes the conversion of sepiapterin to L-erythro-7,8-
CC       dihydrobiopterin, which is then reduced to BH4 by dihydrofolate
CC       reductase, constituting the salvage pathway of BH4 (PubMed:10987137).
CC       {ECO:0000269|PubMed:10987137, ECO:0000269|PubMed:15896778,
CC       ECO:0000269|PubMed:16527408, ECO:0000269|PubMed:17976377}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-erythro-7,8-dihydrobiopterin + NADP(+) = H(+) + NADPH +
CC         sepiapterin; Xref=Rhea:RHEA:18953, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16095, ChEBI:CHEBI:43029, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.1.1.153;
CC         Evidence={ECO:0000269|PubMed:10987137};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18955;
CC         Evidence={ECO:0000269|PubMed:10987137};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin + 2 NADP(+) = 6-
CC         pyruvoyl-5,6,7,8-tetrahydropterin + 2 H(+) + 2 NADPH;
CC         Xref=Rhea:RHEA:32627, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:59560, ChEBI:CHEBI:136564;
CC         EC=1.1.1.153; Evidence={ECO:0000269|PubMed:10987137,
CC         ECO:0000269|PubMed:15896778, ECO:0000269|PubMed:16527408};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:32629;
CC         Evidence={ECO:0000269|PubMed:10987137, ECO:0000269|PubMed:15896778,
CC         ECO:0000269|PubMed:16527408};
CC   -!- ACTIVITY REGULATION: Inhibited by N-acetylserotonin and to a lesser
CC       extent by melatonin. {ECO:0000269|PubMed:10987137}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=51.8 uM for NADPH {ECO:0000269|PubMed:10987137};
CC         KM=40 uM for sepiapterin {ECO:0000269|PubMed:10987137};
CC         Vmax=0.14 umol/min/mg enzyme {ECO:0000269|PubMed:10987137};
CC       pH dependence:
CC         Optimum pH is 5.5. {ECO:0000269|PubMed:10987137};
CC       Temperature dependence:
CC         Optimum temperature is 30 degrees Celsius.
CC         {ECO:0000269|PubMed:10987137};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Mutant cells produce about 3% of
CC       tetrahydropteridines when compared to wild-type production. They
CC       display retarded growth, poor spore viability, impaired mitochondrial
CC       function, and increased susceptibility to oxidative stress induced by
CC       hydroxylamine or cumene-hydroperoxide. In another mutant, it was found
CC       18% of BH4 and 0.6% of DH4 production of the wild-type level.
CC       {ECO:0000269|PubMed:15896778, ECO:0000269|PubMed:17976377}.
CC   -!- SIMILARITY: Belongs to the sepiapterin reductase family. {ECO:0000305}.
CC   -!- CAUTION: Dictyopterin was not identified in one of the enzymatic assays
CC       [PubMed:10987137]. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AAFI02000151; EAL62410.1; -; Genomic_DNA.
DR   EMBL; AF253975; AAF67740.1; -; mRNA.
DR   RefSeq; XP_635919.1; XM_630827.1.
DR   AlphaFoldDB; Q54GP3; -.
DR   SMR; Q54GP3; -.
DR   STRING; 44689.DDB0191275; -.
DR   PaxDb; Q54GP3; -.
DR   PRIDE; Q54GP3; -.
DR   EnsemblProtists; EAL62410; EAL62410; DDB_G0290009.
DR   GeneID; 8627440; -.
DR   KEGG; ddi:DDB_G0290009; -.
DR   dictyBase; DDB_G0290009; spr.
DR   eggNOG; KOG1204; Eukaryota.
DR   HOGENOM; CLU_010194_2_11_1; -.
DR   InParanoid; Q54GP3; -.
DR   OMA; MTVQVQR; -.
DR   PhylomeDB; Q54GP3; -.
DR   Reactome; R-DDI-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-DDI-203615; eNOS activation.
DR   SABIO-RK; Q54GP3; -.
DR   PRO; PR:Q54GP3; -.
DR   Proteomes; UP000002195; Chromosome 5.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004757; F:sepiapterin reductase activity; IDA:dictyBase.
DR   GO; GO:0042559; P:pteridine-containing compound biosynthetic process; IMP:dictyBase.
DR   GO; GO:0140460; P:response to Gram-negative bacterium; HDA:dictyBase.
DR   GO; GO:0006979; P:response to oxidative stress; IDA:dictyBase.
DR   GO; GO:0006729; P:tetrahydrobiopterin biosynthetic process; IDA:dictyBase.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR002347; SDR_fam.
DR   InterPro; IPR006393; Sepiapterin_red.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR01500; sepiapter_red; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; NADP; Oxidoreductase; Reference proteome.
FT   CHAIN           1..267
FT                   /note="Sepiapterin reductase"
FT                   /id="PRO_0000327640"
FT   BINDING         10..16
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         41..42
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         69..70
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         159..160
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         172
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         176
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         204
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         206..211
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         261
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   267 AA;  30187 MW;  46AB80622D788267 CRC64;
     MSKVLAIVTG ASKGFGKAIA QEIVKCNPNK NQLIDLVLFA RSLDGLKSTK ESIETISTNA
     KVIDLQSLDM SNIPDVELKF KSVLENIKWE EYSKICFFNN HGTLYHLGRI EDFSDFKNIQ
     KDNDTNTTSF VVTTSLLVKK LKELGSQYSS EVTIVNSSSL CAIKAFPTWS LYCSSRAYRD
     MFFQALSLEY KLNDKFKVLN YSLGVLDTDM QSQVREECSE DDKSFYVGLK NDGKLINPNR
     SASICSNLVY SHKFETGSHL DYYDLDK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024